GE Healthcare (NYSE:GE) and Elekta (EKTA-B.ST) recently announced that they have inked a global commercial collaboration agreement.
The partnership covers the radiation oncology field. It’s meant to enable the two companies to provide hospitals a comprehensive offering across imaging and treatment for cancer patients.
“Access to radiation therapy is a significant challenge in several parts of the globe. We are pleased that this collaboration is a step in the right direction to make more comprehensive precision health solutions more readily available,” Jan Makela, president and CEO of Imaging at GE Healthcare, said in an April 5 news release.
“Cancer care can only be improved if those in the field work together, and this is one of several partnerships that we are pursuing, for the benefit of caregivers and patients, as we build out our oncology offerings to help enable more precise care,” Makela said.
Elekta CEO Gustaf Salford said the collaboration will allow the companies to jointly promote solutions for each cancer center’s needs.
“Elekta strives to assure that hospitals and cancer centers can create seamless ecosystems that facilitate efficient end-to-end cancer care,” Salford said.
The agreement is non-exclusive. GE Healthcare and Elekta will continue to each offer their solutions using standard interoperability — and facilitate interfaces with any vendor’s systems.
It comes about a year after Siemens Healthineers (ETR:SHL) completed its $16.4 billion acquisition of Varian Medical Systems, boasting that the merger created the most comprehensive cancer care portfolio in the industry.